Pharmafile Logo
Pharmafocus logo
Advanced Search

COVID-19

Showing 15 posts of 602 posts found.

J&J launches second global COVID-19 vaccine trial, evaluating two-dose regimen

November 16, 2020
Research and Development, Sales and Marketing COVID-19, J&J, JJ, Janssen, Vaccine

Johnson & Johnson has kicked off a second global Phase 3 trial to assess the safety and efficacy of its …

News
shutterstock_2

Israel to reserve 8m doses of Pfizer/BioNTech’s COVID-19 vaccine

November 13, 2020
Manufacturing and Production, Medical Communications BioNTech, COVID-19, Pfizer, Vaccine, israel

Israeli Health Minister Yuli Edelstein has confirmed the nation’s plans to strike an agreement with Pfizer to secure eight million …

News
guido_rasi

Guido Rasi steps down as EMA’s Executive Director, Emer Cooke to become first female in the role

November 13, 2020
Medical Communications, Research and Development, Sales and Marketing COVID-19, EMA, EU, pharma

Professor Guido Rasi, Executive Director at the European Medicines Agency (EMA), serves his final day at the European regulator today, …

News
steven_ferdman-getty_images

Pfizer CEO cashes in shares for $5.6m following strong Phase 3 COVID-19 vaccine data

November 12, 2020
Sales and Marketing COVID-19, Pfizer, Vaccine, pharma

With the news that Pfizer and BioNTech’s COVID-19 vaccine candidate demonstrated 90% efficacy in a Phase 3 interim analysis, it …

News
reuters_-_tatyana_makeyeva

First interim Phase 3 data shows promise for Russia’s Sputnik V COVID-19 vaccine

November 11, 2020
Research and Development COVID-19, Russia, Sputnik V, Vaccine

The first interim Phase 3 data for Russia’s Sputnik V COVID-19 vaccine have been released by the Gamaleya Research Center …

News
512px-curevac_in_tubingen_02

CureVac’s COVID-19 vaccine generates immune responses at Phase 1

November 11, 2020
Research and Development COVID-19, CureVac, pharma

German biopharma firm CureVac has unveiled interim analysis data from a Phase1 study of its messenger RNA (mRNA) COVID-19 vaccine, CVnCoV, …

News
vaccination-1215279_960_720

Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis

November 10, 2020
Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …

News
astrazeneca_sign_sky

Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni

November 9, 2020
Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine

AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …

News
1200px-vaccine_image_1

Head of UK’s COVID-19 vaccine taskforce faces questions over biotech fund

November 9, 2020
Sales and Marketing COVID, COVID-19, vaccines

Kate Bingham, the head of the British Government’s vaccine taskforce, faces scrutiny after it was revealed her venture capital firm …

News
novartis_outside_1

Novartis’ arthritis therapy shows no efficacy in hospitalised COVID-19 patients

November 6, 2020
Medical Communications, Research and Development COVID-19, Novatis, canakinumab

Novartis has revealed that its arthritis drug, theinterleukin-1 beta inhibitor canakinumab, in combination with standard of care (SoC), failed to …

News
top_10_image_2

Pharmafile.com’s weekly COVID-19 news round-up

November 6, 2020
Medical Communications COVID, COVID-19, EC, FDA, coronavirus

The top ten news stories this week focus on regulatory approvals as the European Commission has approved GlaxoSmithKline’s Zeljula as …

News
shutterstock_2

Australia secures a further 50m COVID-19 vaccine doses from Novavax and Pfizer/BioNTech

November 5, 2020
Manufacturing and Production Australia, COVID-19, Vaccine

Two more COVID-19 vaccine distribution deals have been signed by the Australian Government, reserving a further 50 million doses to …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

November 4, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, GSK, Sanofi, UK, US, remdesivir

As European nations fall one by one back into lockdown, hopes weigh heavily on a vaccine to pave a path …

News
takeda_usa_pharmaceuticals_u

Takeda commits to deliver 50 million doses of Moderna’s COVID-19 vaccine in Japan

October 29, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Japan, Moderna, Takeda, Vaccine

Takeda has made a commitment with Japan’s Ministry of Health, Labor and Welfare (MHLW) to deliver 50 million doses of …

News
vaccination-1215279_960_720

GSK and Sanofi promise 200m COVID-19 vaccines to international COVAX initiative

October 28, 2020
Manufacturing and Production, Research and Development COVAX, COVID-19, GSK, Sanofi

Sanofi and GSK have committed 200 million doses of their adjuvanted recombinant protein-based COVID-19 vaccine to the COVAX Facility, a …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026